Our nano immuno-engager platform can harness a patient’s own immune system against cancer, while our HER2+ platform will offer a new treatment paradigm for treating HER2+ tumors.
T-NanoBio Therapeutics innovative approach has the potential to create life changing therapies for cancer patients.